NovoCure Limited Convertible Notes Payable, Current
NovoCure Limited (NVCR) had Convertible Notes Payable, Current of $0 as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2026-02-26
- 2025-12-31: Convertible Notes Payable, Current $0.00.
- 2025-09-30: Convertible Notes Payable, Current $560.62M.
- 2025-06-30: Convertible Notes Payable, Current $559.79M.
- 2025-03-31: Convertible Notes Payable, Current $558.97M.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2025-09-30 | $560.62M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $559.79M 10-Q · filed 2025-07-24 |
| 2025-03-31 | $558.97M 10-Q · filed 2025-04-24 |
| 2024-12-31 | $558.16M 10-K · filed 2026-02-26 |
| 2024-09-30 | $557.33M 10-Q · filed 2024-10-30 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |